Apyx Medical CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Royce & Associates LP has disclosed a beneficial ownership of 7.81% of Apyx Medical Corporation's common stock as of June 30, 2026.
NASDAQ
Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a 9.99% beneficial ownership stake in Apyx Medical Corporation as of December 31, 2025.
NASDAQ
Investment adviser Royce & Associates LP has filed an amendment to its Schedule 13G, reporting a 5.95% beneficial ownership stake in Apyx Medical Corporation.
NASDAQ
Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 9.99% in APYX Medical Corporation's common stock as of December 31, 2024.